Clinical Infectious Diseases · 2011 · 4.2K citations · 309 references
PharmacyInfectious DiseasesPediatricsAntimicrobial PharmacotherapyMedical MicrobiologyPediatric Infectious DiseasesAntibiotic ProphylaxisBacterial InfectionsHealthcare-associated InfectionsNosocomial InfectionsPediatric Antibiotic TherapyPediatric Antimicrobial TherapyMethicillin-resistant Staphylococcus Aureus BacteremiaMethicillin-resistant Staphylococcus Aureus EndocarditisMethicillin-resistant Staphylococcus Aureus Infection TreatmentMethicillin-resistant Staphylococcus Aureus TreatmentPediatric Infection TreatmentStaphylococcal Skin InfectionStaphylococcus Aureus Soft Tissue InfectionTreatment Of Skin Infections
Evidence-based guidelines for the management of patients with methicillin-resistant Staphylococcus aureus (MRSA) infections were prepared by an Expert Panel of the Infectious Diseases Society of America (IDSA). The guidelines are intended for use by health care providers who care for adult and pediatric patients with MRSA infections. The guidelines discuss the management of a variety of clinical syndromes associated with MRSA disease, including skin and soft tissue infections (SSTI), bacteremia and endocarditis, pneumonia, bone and joint infections, and central nervous system (CNS) infections. Recommendations are provided regarding vancomycin dosing and monitoring, management of infections due to MRSA strains with reduced susceptibility to vancomycin, and vancomycin treatment failures.
309
R. Phillip Dellinger, Mitchell M. Levy, Julian Bion et al. · Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) · 2008 · 3.9K citations